Rhodes Jennifer J bought ACAD
February 6, 2026 · Form 4 insider transaction
Rhodes Jennifer J bought 12,944 shares of Acadia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,944
Price
$0.00
Total value
N/A
InsiderRhodes Jennifer J
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 6, 2026
Filing dateFebruary 10, 2026
Shares owned after14,559
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.; Includes 595 shares of the Issuer's common stock acquired by the reporting person on May 15, 2025 pursuant to an employee stock purchase plan.